SCHEMBL5674155

SCHEMBL5674155

CC(C)(C)OC(=O)N1CCN(C(=O)NC2(C(=O)O)CCCCC2)CC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.54
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 1/20 0.45
EPHX1 P07099 1/20 0.44
HPGD P15428 1/20 0.43
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
STS P08842 1/20 0.41
GPR119 Q8TDV5 1/20 0.39
NAMPT P43490 1/20 0.38
CTSB P07858 1/20 0.38
CTSS P25774 1/20 0.38
CTSK P43235 1/20 0.38
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5674238 0.85 CYP1A2 (0.48) EPHX2MEN1KMT2AUSP2CTSB
SCHEMBL5142124 0.83 HPGD (0.56) EPHX2KMT2AEPHX1HPGDSTS
SCHEMBL5674894 0.82 MAPT (0.51) MEN1KMT2AMAPTHPGDSMN1; SMN2
SCHEMBL7533918 0.81 CTSB (0.40) EPHX2MEN1KMT2ACTSBCTSS
SCHEMBL17684002 0.80 EPHX1 (0.47) EPHX2EPHX1HPGDUSP2SMN1; SMN2
SCHEMBL5675372 0.79 EPHX2 (0.47) EPHX2KMT2AMAPTSMN1; SMN2CTSB
SCHEMBL5674323 0.79 EPHX2 (0.47) EPHX2MEN1KMT2AEPHX1SMN1; SMN2
SCHEMBL5674901 0.79 MEN1 (0.47) EPHX2MEN1KMT2AMAPTSTS
SCHEMBL1840770 0.78 CTSB (0.47) MEN1KMT2ASMN1; SMN2CTSBCTSS
SCHEMBL1840796 0.78 CTSB (0.47) MEN1KMT2ASMN1; SMN2CTSBCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1616859-B1 Substituted cyclohexyl carboxylic acid compounds SEIKAGAKU KOGYO CO LTD (JP) 2013-09-04 EP claimed
EP-1616859-B1 Substituted cyclohexyl carboxylic acid compounds SEIKAGAKU KOGYO CO LTD (JP) 2013-09-04 EP disclosed
EP-1619189-B1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives SEIKAGAKU KOGYO CO LTD (JP) 2013-09-04 EP disclosed
US-7109275-B2 Co-metering of organic initiators and protective colloids during polymerization reactions AKZO NOBEL N.V. (NL) 2006-09-19 US disclosed
EP-1495057-B1 CO-METERING OF ORGANIC INITIATORS AND PROTECTIVE COLLOIDS DURING POLYMERIZATION REACTIONS AKZO NOBEL NV (NL) 2006-08-02 EP disclosed
EP-1008592-B1 Cyclic amide derivatives which inhibit cathepsin K SEIKAGAKU KOGYO CO LTD (JP) 2006-02-01 EP disclosed
EP-1008592-B1 Cyclic amide derivatives which inhibit cathepsin K SEIKAGAKU KOGYO CO LTD (JP) 2006-02-01 EP disclosed
EP-1619189-A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives SEIKAGAKU CORPORATION (JP) 2006-01-25 EP disclosed
EP-1616867-A1 Hydroxycarboxylic acid derivatives SEIKAGAKU CORPORATION (JP) 2006-01-18 EP disclosed
EP-1616859-A1 Substituted cyclohexyl carboxylic acid compounds SEIKAGAKU CORPORATION (JP) 2006-01-18 EP disclosed
EP-1495057-A1 CO-METERING OF ORGANIC INITIATORS AND PROTECTIVE COLLOIDS DURING POLYMERIZATION REACTIONS Akzo Nobel N.V. (NL) 2005-01-12 EP disclosed
WO-2003087168-A1 CO-METERING OF ORGANIC INITIATORS AND PROTECTIVE COLLOIDS DURING POLYMERIZATION REACTIONS AKZO NOBEL N.V. (NL) 2003-10-23 WO disclosed
US-20030199656-A1 Co-metering of organic initiators and protective colloids during polymerization reactions WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT (GB) 2003-10-23 US disclosed
US-6117870-A USEFUL AS THERAPEUTIC DRUG OR PREVENTIVE DRUG OF ARTHRITIS AND RHEUMATISM DUE TO INCREASE OF BONE RESORPTION IN ADDITION TO BONE DISEASES SUCH AS OSTEOPOROSIS, HYPERCALCEMIA, AND PAGET'S DISEASE FUJIREBIO KABUSHIKI KAISHA (JP) 2000-09-12 US disclosed
EP-1008592-A2 Cyclic amide derivatives which inhibit cathepsin K Fujirebio Kabushiki Kaisha (JP) 2000-06-14 EP disclosed